Click Here to Register »

Executive Sponsors

goBalto
PwC UK

Associate Sponsors

Be The Partner
Bracket Global
HealthiVibe
TrialReach

Exhibitors

Langland
SynteractHCR

Media Partners

MNT
Pharmalicensing

Supporting Partners

British Consulate General
MedCity

Partners / Media

BioCentury
BioPharm Clinical
CanBiotech
Experimental Cancer Medicine Centres (ECMC)
Iptechex Pharmalicensing
PharmaVoice

Overview

We are delighted to present the 2nd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event.DPharm Europe takes on more global examples of disruptive ideas, examples of applying digital technologies and examples of collaborations to advance clinical trials. We are delighted to announce that Sue Collier, Head of Medical Operations for the Salford Lung Study, GSK and Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED Informatics, Roche Pharmaceutical Research and Early Development (pRED) will co-chair the 2016 event. The co-chairs together with the speaking faculty will address:

  • How can we drive innovation in clinical trials into everyday patient care – what are the lessons and the potential benefits to everyday clinical practice?
  • How can we use digital innovation to enable more HCPs and patients to get involved in research on an everyday basis – embed research as part of normal routine clinical care?
  • What can we in the healthcare business learn from technical innovation in other areas of life – smart phones, interactive web-based systems, Facebook, Twitter etc?
Photo Mark Earthy www.earthyphotography.co.uk This image is protected by Copyright

2015 Keynote Discussion with Magnus Essand, Uppsala University, Alexander Masters, iCancer and Craig Lipset, Pfizer.

DPharm Europe has an exciting line up of speakers doing amazing things in how we can better develop therapeutics for the benefit of the patient. We have patients inventing apps and technologies disrupting industry. We have industry disrupting how we create enabled products for product appropriateness. We have government disrupting every obstacle to reach and engage patients and caregivers directly. We have examples of new economic models to drive cures as well as insights into the future of mobile computing, wearables, sensors and so much more.

St Pancras Hotel

St Pancras Renaissance Hotel, London, England.

In the spirit of biomedical research investments to make the St Pancras / Kings Cross area of London the center for R&D innovation, we are pleased to announce that DPharm Europe will be held at the St Pancras Renaissance Hotel in London, UK.

 

 

 

Event History
It was a daunting task to develop the first industry forum on thinking radically different about the way we perform clinical trials, but the result was this conference. The event was first launched in Philadelphia in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.

Jeff Kasher

Dr Jeff Kasher, Founder of Patients Can’t Wait speaking at the 2015 event.

The first DPharm event addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas.

By the time the 2nd annual DPharm program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them. Fast forward to current day, we are looking at how new innovations will attract and retain more people in clinical trials, bring down development timelines and figure what data is really useful.

Photo Mark Earthy www.earthyphotography.co.uk This image is protected by Copyright

Carol Maguire, UCSF engages in Q&A with the presenter.

With support from MedCity, the British Consulate and NIHR Clinical Research Network, we look forward to bringing more global examples of disrupting clinical trials and to collaborating on an even broader scale between industry and others.

Not all innovation is disruptive. However, as a global community, we can continue to drive down the cost of drug development and provide better access to clinical trials through innovation, while greatly enhancing the patient experience.

We look forward to greeting you at the St Pancras Renaissance hotel in London on February 9-10, 2016.

Sincerely,

Valerie Bowling New

 

Valerie Bowling
Executive Director
DPharm Europe

Meredith Sands B&W

 

Meredith Sands
Executive Director, Business Development
DPharm Europe

Jessica Rothenberg B&W

 

Jessica Rothenberg
Marketing Director
DPharm Europe

Elizabeth Bard B&W

 

Elizabeth Bard
Business Development Manager
DPharm Europe

Bridget-bw

 

Bridget L. Murphy
Conference Logistics Planner
DPharm Europe

 

Rob Wright Quote1


Testimonials

  • "I thoroughly enjoyed the conference. It was great to hear from such a wide range of knowledgeable speakers and to meet so many like-minded individuals who are enthusiastic about changing the way we do clinical research."

    - Sue Collier, GSK

  • "I really enjoyed the conference and made some useful connections."

    - Flóra Raffai, Findacure

  • "an excellent conference"

    - Jane Rhodes, Biogen Idec

  • "I thoroughly enjoyed DPharm Europe, it was fantastic to see such a huge emphasis on patients and their families at an industry conference!"

    - Simon Stones, Generation R

  • "It was one of the best conferences I have attend in quite some time. The venue, speaker topics, and format had a very light and more personable feel that allowed for learning and networking to be more casual versus other conferences."

    - Jen Kelly, HealthiVibe

  • "Thank you DPharm team: Great content and rich networking opportunities in a really inspiring environment."

    - Christian Gossens, Roche Pharmaceuticals